Japanese company profile · 7575
Japan Lifeline Co., Ltd.
English company name recorded in Japan's EDINET filer data.
Original Japanese company name: 日本ライフライン株式会社
Name follows the English name recorded in EDINET filer data. English company name source
FY2025 · fiscal year ended March 2026Latest filing date: 2026-06-19What does this company do?
What does this company do?
In its FY2025 public filing, Japan Lifeline Co., Ltd. reports Manufacture and sale of medical devices. The page shows business-level revenue and profit where the source disclosures support comparison.
Japan Lifeline Co., Ltd.'s largest reported business by revenue in FY2025 was Manufacture and sale of medical devices.
The business with the highest reported segment profit in FY2025 was Manufacture and sale of medical devices.
FY2025 · fiscal year ended March 2026 · View original filing ↗ The source document may be in Japanese.
Reported company-wide figures
- Company revenue
- ¥59.19B ↗ FY2025 · fiscal year ended March 2026
- Operating profit
- ¥12.61B ↗ FY2025 · fiscal year ended March 2026
- Comparable margin
- 21.3% ↗ FY2025 · fiscal year ended March 2026
JGAAP · Consolidated company-wide
Company profile
Identity
- Securities code
- 7575
- EDINET code
- E02881
- Corporate number
- 2010701020987
- Listing status
- Listed
- Industry (EDINET filer classification)
- Wholesale trade
Location and fiscal year
- Headquarters
- 東京都品川区 · As filed in Japanese
- Fiscal year end
- 3month
- Latest fiscal year
- FY2025
- Accounting standard
- JGAAP
- P16 data snapshot
- 2026-11-07
Company size
- Employees (consolidated)
- 1,304 people (FY2025)
- Employees (non-consolidated)
- 1,085 people (FY2025)
- Capital stock
- JPY 2.1 billion (FY2025)
Official information
- Latest annual securities report
- Latest annual securities report Opens in a new tab
Public information is organized and presented by P16. EDINET filer list (2026-11-07) Opens in a new tab · EDINET PDL 1.0 terms Opens in a new tab
Business structure
How does it make money?
Revenue leader and profit leader
Manufacture and sale of medical devices
| Business | Sales | Share of company sales | Operating profit | Margin |
|---|---|---|---|---|
| Manufacture and sale of medical devices | ¥59.19B ↗ | — | ¥12.61B ↗ | 21.3% |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended March 2026. Revenue and profit are shown only where the filing and data support a comparison. “—” means a comparable amount was not disclosed. We compare sales to outside customers for each business and the company as a whole, using the same filing, fiscal year and scope. Reported business sales may include sales between businesses. We leave the share blank when the figures cannot be matched.
Company revenue
Company-wide trend
No comparable company-wide annual series is available in the current source snapshot.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
What is growing?
What is growing?
No comparable reported revenue growth is available.
What has changed?
What has changed?
A five-year business-mix comparison is not shown because the available filings do not provide five comparable years on the same basis.
Source
Company profile
These scores summarize company characteristics using public filings. Comparison groups vary by measure. Higher is not always better.
- Growth—No comparable data
- ProfitabilityPeer-position scoreFY2025
99 - Business concentration—No comparable data
- Business change—No comparable data
- Cash generationPeer-position scoreFY2025
96 - Growth persistence—No comparable data
Source
Public filing
FY2025 · fiscal year ended March 2026
The source document may be in Japanese.
Filing ID: S100YEH7
View original filing ↗